NCT01652885View on ClinicalTrials.gov

Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

November 30, 2012

Conditions
Dermatitis, Atopic
Interventions
DRUG

AN2728 Topical Ointment, 2%

AN2728 Topical Ointment, 2%

Trial Locations (6)

27104

Anacor Investigational Site, Winston-Salem

27262

Anacor Investigational Site, High Point

46256

Anacor Investigational Site, Indianapolis

77030

Anacor Investigational Site, Houston

92123

Anacor Investigational Site, San Diego

94538

Anacor Investigational Site, Fremont

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01652885 - Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitis | Biotech Hunter | Biotech Hunter